Melphalan triggered the DNA damage response pathway of various multiple myeloma (MM) cell lines, which stimulated the in vitro up-regulation of MICA/B and PVR through the ATM-ATR pathway [145,146]. The gene discussed is PVR; the disease is Miyoshi myopathy.